Morning Bid: Fed hawks re-emerge, dollar pumped
A look at the day ahead in U.S. and global markets from Mike DolanAmid all the hand-wringing over the debt...
archiveHUMDIS
UK economy makes slow start to 2023 as inflation headwinds persist
UK GDP grows 0.1% in Q1 2023, matching forecastsEconomy unexpectedly shrank by 0.3% in MarchStrikes and weak retail weigh on...
Pfizer, BioNTech propose EU pays half for each cancelled COVID dose, Financial Times reports
April 30 (Reuters) - Pfizer Inc (PFE.N) and BioNTech's (22UAy.DE) new proposal to the European Union, amid a glut of...
Morning Bid: April boomlet mocks recession script
A look at the day ahead in U.S. and global markets from Mike DolanThe signal is still lost in an...
Dollar steadies after strong U.S. bank results
TOKYO, April 20 (Reuters) - The U.S. dollar steadied on Thursday after strong U.S. banking results firmed up expectations that...
Seaplanes and tech gods: Spain’s drive to dish out $84 billion of EU cash
MADRID, April 20 (Reuters) - A request for seaplanes needed to fight forest fires is red-flagged because it could harm...
Morning Bid: Bank angst persists, unnerves Europe
A look at the day ahead in U.S. and global markets from Mike DolanAfter a week of sweeping interest rate...
Safe-haven yen regains footing as caution builds over bank contagion
TOKYO, March 20 (Reuters) - The safe-haven yen rebounded from early steep declines and the risk-sensitive Australian and New Zealand...
Galderma posts 2022 revenue growth ahead of planned IPO
2022 revenue growth up 13.9% to $3.8bn net salesCore earnings (EBITDA) up 14.5% to $791mExpects 6%-9% net sales growth 2023FRANKFURT,...
Novo obesity drug to launch in the UK soon, says watchdog
LONDON, March 8 (Reuters) - Novo Nordisk's (NOVOb.CO) keenly anticipated weight loss medicine, Wegovy, will soon be made available to...
